vimarsana.com
Home
Live Updates
FDA OKs Risankizumab for Crohns Disease : vimarsana.com
FDA OKs Risankizumab for Crohn's Disease
Approval marks the third indication for the IL-23 inhibitor in adults
Related Keywords
New York ,
United States ,
Chicago ,
Illinois ,
Zaina Hamza ,
Marla Dubinsky ,
Icahn School Of Medicine At Mount Sinai ,
Icahn School ,
Mount Sinai ,
New York City ,
Disease Activity Index ,
Simple Endoscopic Score ,
Medpage Today ,
vimarsana.com © 2020. All Rights Reserved.